In upholding Martin Shkreli's lifetime ban, judge rules any statement he makes about pharma could be a violation
A federal judge in New York has upheld the lifetime industry ban placed on Martin Shkreli last month after the ex-Pharma Bro appealed the decision.
Shkreli and his lawyers largely objected to the scope of the ban, arguing it was too vague and burdensome. The latest opinion Friday, however, essentially prevents Shkreli from making any public statements about the pharma industry at all.
In his appeal, Shkreli said the lifetime ban violated his First Amendment right to free speech and his Fifth Amendment rights in forcing him to sell his shares in Phoenixus AG, the parent company of Vyera Pharmaceuticals. He went further, saying the ban as previously written did not say whether or not he could take a job at an academic institution working with biopharmas.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters